title: Discontinuation of statins in routine care settings: a cohort study.
abstract: BACKGROUND
  Systematic data on discontinuation of statins in routine practice of medicine are limited.
  
  
  OBJECTIVE
  To investigate the reasons for statin discontinuation and the role of statin-related events (clinical events or symptoms believed to have been caused by statins) in routine care settings.
  
  
  METHODS
  A retrospective cohort study.
  
  
  METHODS
  Practices affiliated with Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
  
  
  METHODS
  Adults who received a statin prescription between 1 January 2000 and 31 December 2008.
  
  
  METHODS
  Information on reasons for statin discontinuations was obtained from a combination of structured electronic medical record entries and analysis of electronic provider notes by validated software.
  
  
  RESULTS
  Statins were discontinued at least temporarily for 57 292 of 107 835 patients. Statin-related events were documented for 18 778 (17.4%) patients. Of these, 11 124 had statins discontinued at least temporarily; 6579 were rechallenged with a statin over the subsequent 12 months. Most patients who were rechallenged (92.2%) were still taking a statin 12 months after the statin-related event. Among the 2721 patients who were rechallenged with the same statin to which they had a statin-related event, 1295 were receiving the same statin 12 months later, and 996 of them were receiving the same or a higher dose.
  
  
  CONCLUSIONS
  Statin discontinuations and statin-related events were assessed in practices affiliated with 2 academic medical centers. Utilization of secondary data could have led to missing or misinterpreted data. Natural-language-processing tools used to compensate for the low (30%) proportion of reasons for statin discontinuation documented in structured electronic medical record fields are not perfectly accurate.
  
  
  CONCLUSIONS
  Statin-related events are commonly reported and often lead to statin discontinuation. However, most patients who are rechallenged can tolerate statins long-term. This suggests that many of the statin-related events may have other causes, are tolerable, or may be specific to individual statins rather than the entire drug class.
  
  
  BACKGROUND
  National Library of Medicine, Diabetes Action Research and Education Foundation, and Chinese National Key Program of Clinical Science.
authors.affiliation: Key Laboratory of Endocrinology, Ministry of Health, PekingUnion Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
authors.forename: Huabing
authors.initials: H
authors.lastname: Zhang
authors.forename: Jorge
authors.initials: J
authors.lastname: Plutzky
authors.forename: Stephen
authors.initials: S
authors.lastname: Skentzos
authors.forename: Fritha
authors.initials: F
authors.lastname: Morrison
authors.forename: Perry
authors.initials: P
authors.lastname: Mar
authors.forename: Maria
authors.initials: M
authors.lastname: Shubina
authors.forename: Alexander
authors.initials: A
authors.lastname: Turchin
mesh_terms: D004282:Documentation; D057286:Electronic Health Records; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D009323:Natural Language Processing; D012189:Retrospective Studies; D028761:Withholding Treatment
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
references.citation: Heart. 2002 Sep;88(3):229-33
references.pmid: 12181210
references.citation: JAMA. 2002 Jan 16;287(3):337-44
references.pmid: 11790213
references.citation: Arch Intern Med. 2005 Dec 12-26;165(22):2671-6
references.pmid: 16344427
references.citation: JAMA. 2002 Jul 24-31;288(4):462-7
references.pmid: 12132976
references.citation: J Cardiovasc Nurs. 2009 Sep-Oct;24(5):371-9
references.pmid: 19707097
references.citation: Int J Cardiol. 2010 Apr 15;140(2):226-35
references.pmid: 19081646
references.citation: AMIA Annu Symp Proc. 2011;2011:1270-9
references.pmid: 22195188
references.citation: Curr Pharm Des. 2011 Nov;17(33):3669-89
references.pmid: 22074437
references.citation: Stroke. 2002 Sep;33(9):2337-41
references.pmid: 12215610
references.citation: Lancet. 2007 Nov 24;370(9601):1781-90
references.pmid: 17559928
references.citation: Am J Cardiol. 2008 Feb 15;101(4):483-5
references.pmid: 18312762
references.citation: Clin Ther. 2006 Jun;28(6):933-42
references.pmid: 16860175
references.citation: Am J Cardiol. 2003 Jul 15;92(2):152-60
references.pmid: 12860216
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: JAMA. 1986 Nov 28;256(20):2823-8
references.pmid: 3773199
references.citation: Circulation. 2002 Aug 20;106(8):1024-8
references.pmid: 12186811
references.citation: Circulation. 2002 Mar 26;105(12):1446-52
references.pmid: 11914253
references.citation: Am Heart J. 2008 Apr;155(4):772-9
references.pmid: 18371492
references.citation: N Engl J Med. 2010 Aug 5;363(6):501-4
references.pmid: 20647183
references.citation: JAMA. 2002 Jul 24-31;288(4):455-61
references.pmid: 12132975
references.citation: Cleve Clin J Med. 2011 Jun;78(6):393-403
references.pmid: 21632911
references.citation: J Gen Intern Med. 2008 Aug;23(8):1182-6
references.pmid: 18449611
references.citation: Ann Pharmacother. 2007 Nov;41(11):1805-11
references.pmid: 17925498
references.citation: Perm J. 2010 Spring;14(1):4-10
references.pmid: 20740125
references.citation: N Engl J Med. 1996 Oct 3;335(14):1001-9
references.pmid: 8801446
references.citation: J Clin Pharm Ther. 2011 Jun;36(3):336-41
references.pmid: 21414023
references.citation: Circulation. 2006 Dec 19;114(25):2788-97
references.pmid: 17159064
references.citation: J Gen Intern Med. 2004 Jun;19(6):638-45
references.pmid: 15209602
references.citation: N Engl J Med. 1997 Jan 16;336(3):153-62
references.pmid: 8992351
references.citation: Lancet. 2005 Oct 8;366(9493):1267-78
references.pmid: 16214597
references.citation: Lancet. 2012 Aug 11;380(9841):581-90
references.pmid: 22607822
references.citation: Curr Med Res Opin. 2008 Nov;24(11):3059-62
references.pmid: 18826752
references.citation: JAMA. 2007 Jan 10;297(2):177-86
references.pmid: 17213401
references.citation: Ann Pharmacother. 2008 Mar;42(3):341-6
references.pmid: 18285559
references.citation: Diabetes Metab Syndr Obes. 2011;4:155-66
references.pmid: 21779147
references.citation: J Epidemiol Community Health. 2009 Feb;63(2):140-6
references.pmid: 19074182
references.citation: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004816
references.pmid: 21249663
references.citation: J Am Coll Cardiol. 1998 Sep;32(3):665-72
references.pmid: 9741509
references.citation: Lancet. 1994 Nov 19;344(8934):1383-9
references.pmid: 7968073
references.citation: JAMA. 1998 May 13;279(18):1458-62
references.pmid: 9600480
references.citation: N Engl J Med. 2011 Dec 15;365(24):2250-1
references.pmid: 22085320
references.citation: Am J Cardiol. 2006 Apr 17;97(8A):52C-60C
references.pmid: 16581329
references.citation: Am J Cardiol. 2009 Feb 1;103(3):393-4
references.pmid: 19166695
references.citation: AMIA Annu Symp Proc. 2008 Nov 06;:71-5
references.pmid: 18999230
references.citation: Cardiovasc Drugs Ther. 2005 Dec;19(6):403-14
references.pmid: 16453090
references.citation: Ann Intern Med. 1995 May 1;122(9):681-8
references.pmid: 7702231